The Reject Shop (TRS) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Jan, 2026Executive summary
FY 2024 sales reached AUD 852.7 million, up 4.1% year-over-year, with comparable store sales up 2.6%.
Gross profit (pre-AASB 16) was AUD 339 million, up 5% year-over-year, while EBIT (pre-AASB 16) fell 41.3% to AUD 5.4 million.
Statutory NPAT was AUD 4.7 million, down 36% compared to the prior period, reflecting margin and cost pressures and the absence of prior year one-off insurance income.
The business ended the year with a strong balance sheet: AUD 50 million in cash, no drawn debt, and 385 stores nationwide.
Interim dividend of AUD 0.10 per share paid (80% of FY 2024 NPAT); no final dividend declared.
Financial highlights
Gross profit margin (pre-AASB 16) improved by 35 basis points to 39.8% year-over-year.
Comp store sales grew 2.6% for the year, with stronger growth in the second half (3.1%).
Cost of doing business margin increased to 37.7% of sales from 36.8% last year.
Store labor costs rose to 14.6% of sales, up from 13.6% last year.
Inventory closed at AUD 146.4 million, up from AUD 135.6 million, mainly due to higher consumables inventory; stock turn declined to 3.5x.
Outlook and guidance
FY 2025 focus areas: improving gross profit margin, managing costs in a high inflation environment, and expanding the store network.
15-20 new store openings targeted for FY 2025, with about five closures expected.
Gross profit margin expected to be in the 40%-41% range, with product mix above 50% consumables.
Early FY 2025 sales up 1.5% year-over-year, comp store sales up 0.3%.
Latest events from The Reject Shop
- Record sales, margin improvement, and strategic store growth drive positive outlook.TRS
AGM 202419 Jan 2026 - Acquisition at $6.68/share targets July 2025 close, expanding international growth and synergies.TRS
M&A Announcement26 Dec 2025 - Record sales and profit growth, higher margins, and strong cash flow support expansion.TRS
H1 202517 Dec 2025 - Shareholders voted on a $6.68 per share acquisition with a special dividend and board support.TRS
Scheme Meeting 20259 Nov 2025